Antiphospholipid Antibodies in Severe COVID-19: Frequency, Clinical Features, and 12-Week Follow-Up.

Saved in:
Bibliographic Details
Title: Antiphospholipid Antibodies in Severe COVID-19: Frequency, Clinical Features, and 12-Week Follow-Up.
Authors: Hasan MN; Internal Medicine, Bangabandhu Sheikh Mujib Medical University, Dhaka, BGD., Chowdhury FR; Internal Medicine, Bangabandhu Sheikh Mujib Medical University, Dhaka, BGD., Islam KMK; Hematology, Bangladesh Medical University, Dhaka, BGD., Sami CA; Medicine, Dhaka Community Medical College, Dhaka , BGD.; Internal Medicine, Bangabandhu Sheikh Mujib Medical University, Dhaka, BGD., Islam MT; Internal Medicine, Bangabandhu Sheikh Mujib Medical University, Dhaka, BGD.
Source: Cureus [Cureus] 2026 Jan 03; Vol. 18 (1), pp. e100657. Date of Electronic Publication: 2026 Jan 03 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Cureus, Inc Country of Publication: United States NLM ID: 101596737 Publication Model: eCollection Cited Medium: Print ISSN: 2168-8184 (Print) Linking ISSN: 21688184 NLM ISO Abbreviation: Cureus Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2168-8184
DOI:10.7759/cureus.100657